Literature DB >> 6339229

Reactive metabolites of phenacetin and acetaminophen: a review.

J A Hinson.   

Abstract

Phenacetin can be metabolized to reactive metabolites by a variety of mechanisms. (1) Phenacetin can be N-hydroxylated, and the resulting N-hydroxyphenacetin can be sulfated or glucuronidated. Whereas phenacetin N-O sulfate immediately rearranges to form a reactive metabolite which may covalently bind to protein, phenacetin N-O glucuronide slowly rearranges to form reactive metabolites. Incubation of the purified phenacetin N-O glucuronide under a variety of conditions suggests that N-acetyl-p-benzoquinone imine is a reactive metabolite. This metabolite covalently binds to protein, reacts with glutathione to form an acetaminophen-glutathione conjugate, is reduced by ascorbate to acetaminophen or is partially hydrolyzed to acetamide. (2) Phenacetin can be O-deethylated to acetaminophen, and acetaminophen can be converted directly to a reactive metabolite which may be also N-acetyl-p-benzoquinone imine. (3) Phenacetin can be sequentially N-hydroxylated and O-deethylated to N-hydroxyacetaminophen which spontaneously dehydrates to N-acetyl-p-benzoquinone imine. (4) Phenacetin can be 3, 4-epoxidated to form an alkylating and an arylating metabolite. In the presence of glutathione, a S-ethylglutathione conjugate and an acetaminophen-glutathione conjugate are formed. In the absence of glutathione, the alkylating metabolite may bind to protein and the arylating metabolite is completely hydrolyzed to acetamide and another arylating metabolite which may bind to protein. The structures of the alkylating and arylating metabolites are unknown. Control experiments have shown that in pathway (1) the phenolic oxygen of the acetaminophenglutathione conjugate is derived from water, whereas in pathways (2) and (3) the phenolic oxygen of this metabolite is derived from phenacetin. In pathway (4) the phenolic oxygen was 50% derived from molecular oxygen and 50% from phenacetin. Administration of [p-(18)0]phenacetin to hamsters revealed only a 10% loss of (18)0 in the acetaminophen mercapturic acid (the further metabolic product of the glutathione conjugate) which suggests that, in the hamster, pathways (2) and/or (3) are the primary mechanism of conversion of phenacetin to reactive metabolites in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339229      PMCID: PMC1569121          DOI: 10.1289/ehp.834971

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  28 in total

Review 1.  Analgesic abuse and renal disease.

Authors:  T Murray; M Goldberg
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin.

Authors:  J A Hinson; S D Nelson; J R Mitchell
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

3.  N-hydroxylation of p-chloroacetanilde in hamsters.

Authors:  J A Hinson; J R Mitchell; D J Jollow
Journal:  Biochem Pharmacol       Date:  1976-03-01       Impact factor: 5.858

4.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione.

Authors:  J R Mitchell; D J Jollow; W Z Potter; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

5.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

6.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism.

Authors:  J R Mitchell; D J Jollow; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

7.  Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation.

Authors:  G J Mulder; J A Hinson; J R Gillette
Journal:  Biochem Pharmacol       Date:  1977-02-01       Impact factor: 5.858

8.  Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.

Authors:  W Z Potter; D C Davis; J R Mitchell; D J Jollow; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

9.  N-Hydroxylation of phenacetin by hamster liver microsomes.

Authors:  J A Hinson; J R Mitchell
Journal:  Drug Metab Dispos       Date:  1976 Sep-Oct       Impact factor: 3.922

10.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen.

Authors:  D J Jollow; S S Thorgeirsson; W Z Potter; M Hashimoto; J R Mitchell
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

View more
  11 in total

1.  Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Long-term culture and cryopreservation does not affect the stability and functionality of human embryonic stem cell-derived hepatocyte-like cells.

Authors:  Arundhati Mandal; Sheena Raju; Chandra Viswanathan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-20       Impact factor: 2.416

3.  Pharmacokinetics of paracetamol in Göttingen minipigs: in vivo studies and modeling to elucidate physiological determinants of absorption.

Authors:  Claudia Suenderhauf; Gerald Tuffin; Helle Lorentsen; Hans-Peter Grimm; Christophe Flament; Neil Parrott
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

4.  Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.

Authors:  Angelo Agathanggelou; Victoria J Weston; Tracey Perry; Nicholas J Davies; Anna Skowronska; Daniel T Payne; John S Fossey; Ceri E Oldreive; Wenbin Wei; Guy Pratt; Helen Parry; David Oscier; Steve J Coles; Paul S Hole; Richard L Darley; Michael McMahon; John D Hayes; Paul Moss; Grant S Stewart; A Malcolm R Taylor; Tatjana Stankovic
Journal:  Haematologica       Date:  2015-04-03       Impact factor: 9.941

Review 5.  Paracetamol and phenacetin.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Activation mechanisms to chemical toxicity.

Authors:  D V Parke
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

7.  Modeling the Bioactivation and Subsequent Reactivity of Drugs.

Authors:  Tyler B Hughes; Noah Flynn; Na Le Dang; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

8.  Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats.

Authors:  Katsunori Yamaura; Maki Shimada; Noriyuki Nakayama; Koichi Ueno
Journal:  Pharmacognosy Res       Date:  2011-10

9.  Impacts of diphenylamine NSAID halogenation on bioactivation risks.

Authors:  Mary Alexandra Schleiff; Sasin Payakachat; Benjamin Mark Schleiff; S Joshua Swamidass; Gunnar Boysen; Grover Paul Miller
Journal:  Toxicology       Date:  2021-06-06       Impact factor: 4.571

10.  Protective effects of natsumikan (Citrus natsudaidai) extract on acetaminophen-induced lethal hepatotoxicity in mice.

Authors:  Katsunori Yamaura; Noriyuki Nakayama; Maki Shimada; Koichi Ueno
Journal:  Pharmacognosy Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.